Leap Depreciation And Amortization vs Total Current Liabilities Analysis

LPTX Stock

USD 2.98 0.06 2.05%

Leap Therapeutics financial indicator trend analysis is infinitely more than just investigating Leap Therapeutics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Leap Therapeutics is a good investment. Please check the relationship between Leap Therapeutics Depreciation And Amortization and its Total Current Liabilities accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Leap Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Leap Stock please use our How to Invest in Leap Therapeutics guide.

Depreciation And Amortization vs Total Current Liabilities

Depreciation And Amortization vs Total Current Liabilities Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Leap Therapeutics Depreciation And Amortization account and Total Current Liabilities. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Leap Therapeutics' Depreciation And Amortization and Total Current Liabilities is -0.6. Overlapping area represents the amount of variation of Depreciation And Amortization that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Leap Therapeutics, assuming nothing else is changed. The correlation between historical values of Leap Therapeutics' Depreciation And Amortization and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Depreciation And Amortization of Leap Therapeutics are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Depreciation And Amortization i.e., Leap Therapeutics' Depreciation And Amortization and Total Current Liabilities go up and down completely randomly.

Correlation Coefficient

-0.6

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Depreciation And Amortization

The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.

Total Current Liabilities

Total Current Liabilities is an item on Leap Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Leap Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most indicators from Leap Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Leap Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Leap Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Leap Stock please use our How to Invest in Leap Therapeutics guide.Selling General Administrative is likely to drop to about 8.7 M in 2024. Tax Provision is expected to grow at the current pace this year

Leap Therapeutics fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock	Net Tangible Assets	Other Assets	Property Plant Equipment	Short Term Debt
Total Assets		0.59	0.02	0.81	0.17	-0.92	-0.64	0.45	0.96	-0.27	-0.1	1.0	0.11	0.8	0.59	-0.28	0.44	0.74	0.33	0.23	1.0	0.29	0.69	0.08	-0.05	-0.34
Other Current Liab	0.59		0.41	0.32	0.29	-0.55	-0.72	0.76	0.6	0.41	0.03	0.57	0.41	0.5	0.57	-0.54	0.12	0.72	0.76	0.38	0.57	-0.01	0.6	0.54	0.28	-0.12
Total Current Liabilities	0.02	0.41		-0.51	-0.09	0.14	-0.31	0.48	0.05	0.38	0.52	-0.01	0.83	0.09	0.2	0.17	-0.34	0.13	0.27	-0.06	0.01	-0.89	-0.27	0.67	-0.02	0.81
Total Stockholder Equity	0.81	0.32	-0.51		0.27	-0.89	-0.52	0.28	0.77	-0.35	-0.31	0.83	-0.37	0.74	0.55	-0.41	0.5	0.69	0.17	0.32	0.82	0.77	0.8	-0.21	0.14	-0.79
Property Plant And Equipment Net	0.17	0.29	-0.09	0.27		-0.2	-0.31	0.31	0.15	0.6	0.16	0.16	-0.24	0.26	0.15	-0.3	0.06	0.35	0.05	0.98	0.15	0.28	0.27	0.25	0.65	-0.32
Net Debt	-0.92	-0.55	0.14	-0.89	-0.2		0.72	-0.54	-0.95	0.29	0.23	-0.92	0.03	-0.84	-0.71	0.51	-0.53	-0.83	-0.4	-0.27	-0.92	-0.48	-0.88	-0.01	-0.07	0.55
Retained Earnings	-0.64	-0.72	-0.31	-0.52	-0.31	0.72		-0.94	-0.67	-0.12	-0.31	-0.63	-0.27	-0.87	-0.92	0.46	0.06	-0.97	-0.6	-0.43	-0.64	-0.14	-0.6	-0.62	-0.46	0.26
Accounts Payable	0.45	0.76	0.48	0.28	0.31	-0.54	-0.94		0.52	0.3	0.36	0.43	0.43	0.69	0.82	-0.46	-0.1	0.87	0.67	0.41	0.44	-0.05	0.5	0.7	0.5	-0.1
Cash	0.96	0.6	0.05	0.77	0.15	-0.95	-0.67	0.52		-0.29	-0.15	0.96	0.13	0.77	0.61	-0.42	0.5	0.75	0.42	0.22	0.96	0.29	0.77	0.09	-0.07	-0.35
Non Current Assets Total	-0.27	0.41	0.38	-0.35	0.6	0.29	-0.12	0.3	-0.29		0.26	-0.3	0.22	-0.13	-0.03	-0.26	-0.23	0.07	0.19	0.56	-0.29	-0.28	-0.06	0.5	0.47	0.22
Non Currrent Assets Other	-0.1	0.03	0.52	-0.31	0.16	0.23	-0.31	0.36	-0.15	0.26		-0.11	0.45	0.1	0.09	0.29	-0.75	0.12	0.16	0.16	-0.1	-0.41	-0.5	0.79	0.16	0.34
Cash And Short Term Investments	1.0	0.57	-0.01	0.83	0.16	-0.92	-0.63	0.43	0.96	-0.3	-0.11		0.08	0.8	0.59	-0.28	0.44	0.73	0.31	0.23	1.0	0.32	0.69	0.06	-0.05	-0.37
Net Receivables	0.11	0.41	0.83	-0.37	-0.24	0.03	-0.27	0.43	0.13	0.22	0.45	0.08		0.08	0.15	0.13	-0.19	0.12	0.47	-0.25	0.11	-0.72	-0.18	0.5	-0.14	0.64
Common Stock Total Equity	0.8	0.5	0.09	0.74	0.26	-0.84	-0.87	0.69	0.77	-0.13	0.1	0.8	0.08		0.91	-0.31	0.17	0.92	0.26	0.37	0.8	0.27	0.64	0.27	0.37	-0.33
Common Stock Shares Outstanding	0.59	0.57	0.2	0.55	0.15	-0.71	-0.92	0.82	0.61	-0.03	0.09	0.59	0.15	0.91		-0.41	0.04	0.92	0.4	0.29	0.59	0.17	0.62	0.38	0.49	-0.26
Non Current Liabilities Total	-0.28	-0.54	0.17	-0.41	-0.3	0.51	0.46	-0.46	-0.42	-0.26	0.29	-0.28	0.13	-0.31	-0.41		-0.42	-0.52	-0.59	-0.34	-0.28	-0.44	-0.75	-0.11	-0.24	0.53
Other Current Assets	0.44	0.12	-0.34	0.5	0.06	-0.53	0.06	-0.1	0.5	-0.23	-0.75	0.44	-0.19	0.17	0.04	-0.42		0.12	-0.05	0.03	0.44	0.36	0.63	-0.67	-0.15	-0.32
Other Stockholder Equity	0.74	0.72	0.13	0.69	0.35	-0.83	-0.97	0.87	0.75	0.07	0.12	0.73	0.12	0.92	0.92	-0.52	0.12		0.53	0.46	0.73	0.31	0.75	0.45	0.44	-0.42
Total Liab	0.33	0.76	0.27	0.17	0.05	-0.4	-0.6	0.67	0.42	0.19	0.16	0.31	0.47	0.26	0.4	-0.59	-0.05	0.53		0.12	0.33	0.07	0.45	0.53	0.12	-0.22
Property Plant And Equipment Gross	0.23	0.38	-0.06	0.32	0.98	-0.27	-0.43	0.41	0.22	0.56	0.16	0.23	-0.25	0.37	0.29	-0.34	0.03	0.46	0.12		0.22	0.3	0.34	0.31	0.73	-0.34
Total Current Assets	1.0	0.57	0.01	0.82	0.15	-0.92	-0.64	0.44	0.96	-0.29	-0.1	1.0	0.11	0.8	0.59	-0.28	0.44	0.73	0.33	0.22		0.3	0.69	0.07	-0.06	-0.35
Common Stock	0.29	-0.01	-0.89	0.77	0.28	-0.48	-0.14	-0.05	0.29	-0.28	-0.41	0.32	-0.72	0.27	0.17	-0.44	0.36	0.31	0.07	0.3	0.3		0.59	-0.39	0.23	-0.99
Net Tangible Assets	0.69	0.6	-0.27	0.8	0.27	-0.88	-0.6	0.5	0.77	-0.06	-0.5	0.69	-0.18	0.64	0.62	-0.75	0.63	0.75	0.45	0.34	0.69	0.59		-0.09	0.19	-0.66
Other Assets	0.08	0.54	0.67	-0.21	0.25	-0.01	-0.62	0.7	0.09	0.5	0.79	0.06	0.5	0.27	0.38	-0.11	-0.67	0.45	0.53	0.31	0.07	-0.39	-0.09		0.27	0.25
Property Plant Equipment	-0.05	0.28	-0.02	0.14	0.65	-0.07	-0.46	0.5	-0.07	0.47	0.16	-0.05	-0.14	0.37	0.49	-0.24	-0.15	0.44	0.12	0.73	-0.06	0.23	0.19	0.27		-0.26
Short Term Debt	-0.34	-0.12	0.81	-0.79	-0.32	0.55	0.26	-0.1	-0.35	0.22	0.34	-0.37	0.64	-0.33	-0.26	0.53	-0.32	-0.42	-0.22	-0.34	-0.35	-0.99	-0.66	0.25	-0.26

Click cells to compare fundamentals

Leap Therapeutics Account Relationship Matchups

Leap Therapeutics fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	7.4M	54.4M	117.9M	70.4M	72.8M	45.2M
Other Current Liab	3.4M	3.0M	4.9M	4.7M	5.7M	3.0M
Total Current Liabilities	8.5M	7.4M	10.0M	11.2M	12.7M	9.7M
Total Stockholder Equity	(1.7M)	46.7M	107.9M	58.9M	60.1M	63.1M
Property Plant And Equipment Net	1.2M	593K	495K	689K	262K	444.1K
Net Debt	(2.9M)	(51.5M)	(114.4M)	(64.8M)	(70.4M)	(66.9M)
Retained Earnings	(195.2M)	(223.0M)	(263.6M)	(318.2M)	(399.6M)	(379.6M)
Accounts Payable	4.6M	2.7M	4.2M	5.7M	6.5M	6.8M
Cash	3.9M	52.1M	114.9M	65.5M	70.6M	38.1M
Non Current Assets Total	3.2M	2.1M	1.0M	2.4M	1.2M	1.9M
Non Currrent Assets Other	1.9M	1.3M	383K	1.7M	966K	1.3M
Cash And Short Term Investments	3.9M	52.1M	114.9M	65.5M	70.6M	42.0M
Net Receivables	185K	73K	1.2M	2.1M	771K	1.0M
Common Stock Total Equity	15K	24K	60K	88K	101.2K	106.3K
Common Stock Shares Outstanding	2.3M	5.9M	8.6M	11.3M	20.4M	21.5M
Liabilities And Stockholders Equity	7.4M	54.4M	117.9M	70.4M	72.8M	45.2M
Non Current Liabilities Total	3.4M	711K	348K	37K	262K	0.0
Other Current Assets	165K	130K	769K	351K	183K	284.3K
Other Stockholder Equity	193.3M	270.2M	371.6M	376.8M	459.6M	482.6M
Total Liab	9.2M	7.7M	10.0M	11.5M	12.7M	8.8M
Property Plant And Equipment Gross	1.2M	593K	495K	689K	483K	464.4K
Total Current Assets	4.2M	52.3M	116.9M	68.0M	71.6M	43.3M
Accumulated Other Comprehensive Income	76K	(579K)	(267K)	128K	106K	100.7K
Common Stock	24K	60K	88K	99K	26K	27.3K
Net Tangible Assets	(1.7M)	46.7M	107.9M	58.9M	67.7M	71.1M
Other Assets	2.1M	2.0M	542K	1.7M	2.0M	1.5M
Property Plant Equipment	1.2M	65K	36K	689K	792.4K	832.0K
Capital Surpluse	162.4M	193.3M	270.2M	371.6M	427.4M	448.8M
Deferred Long Term Liab	162K	831K	345K	576K	518.4K	442.1K
Non Current Liabilities Other	3.4M	159K	348K	37K	33.3K	31.6K
Retained Earnings Total Equity	(153.5M)	(195.2M)	(223.0M)	(263.6M)	(237.2M)	(249.1M)
Net Invested Capital	(1.7M)	46.7M	107.9M	58.9M	60.1M	45.9M
Net Working Capital	(4.2M)	44.9M	106.9M	56.7M	58.9M	46.5M
Capital Stock	24K	60K	88K	99K	26K	24.7K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Leap Stock Analysis

When running Leap Therapeutics' price analysis, check to measure Leap Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Leap Therapeutics is operating at the current time. Most of Leap Therapeutics' value examination focuses on studying past and present price action to predict the probability of Leap Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Leap Therapeutics' price. Additionally, you may evaluate how the addition of Leap Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Leap Depreciation And Amortization vs Total Current Liabilities Analysis

Depreciation And Amortization vs Total Current Liabilities

Depreciation And Amortization vs Total Current Liabilities Correlation Analysis

Correlation Coefficient

Depreciation And Amortization

Total Current Liabilities

Leap Therapeutics fundamental ratios Correlations

Leap Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Leap Therapeutics fundamental ratios Accounts

Also Currently Popular

Additional Tools for Leap Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Cash And Short Term Investments
Property Plant And Equipment Gross	+ 0.98	Property Plant And Equipment Net
Cash	+ 0.96	Total Assets
Cash And Short Term Investments	+ 0.96	Cash

Short Term Debt	- 0.99	Common Stock
Other Stockholder Equity	- 0.97	Retained Earnings
Cash	- 0.95	Net Debt
Accounts Payable	- 0.94	Retained Earnings
Common Stock Shares Outstanding	- 0.92	Retained Earnings
Total Current Assets	- 0.92	Net Debt